The following is a summary of “Efficacy and Safety of Tildrakizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis ...

Plaque psoriasis is the most common type of psoriasis ... People who follow their treatment plan rarely have to endure severe scalp psoriasis for long. Psoriasis support groups can also offer ...

There’s no cure for psoriasis, but treatment can help you feel better. You may need topical, oral, or body-wide (systemic) treatments. Even if you have severe ... If you have scalp psoriasis ...

This guide explores the best practices, from selecting styles to managing flare-ups if you are living with scalp psoriasis.

Medically reviewed by Susan Bard, MD Psoriasis is a skin condition that causes skin to appear scaly and inflamed. It occurs ...

The results are from the phase 3b, interventional, multicenter, open-label, single-arm aIMM (ClinicalTrials.gov Identifier: NCT04102007) trial, which evaluated the efficacy and safety of directly ...

No significant differences in clinical outcomes were observed between ABP 654 and ustekinumab reference product in patients with plaque psoriasis, including among patients who transitioned from ...

"The approval of Sotyktu represents an exciting day for patients suffering from moderate-to-severe plaque psoriasis who are not satisfied with topical and conventional treatments," said Samit ...

"Plaque psoriasis often affects patients more severely than can be measured by body surface area alone, particularly for those with manifestations in difficult-to-treat areas like the scalp," she ...

But, unlike plaque psoriasis, the rash isn't very thick and tends to be separate rather than clustered. Guttate psoriasis manifests with the eruption of dozens or even hundreds of small, ...